Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
暂无分享,去创建一个
J. O'dell | C. Haire | N. Erikson | W. Drymalski | W. Palmer | P. Eckhoff | V. Garwood | P. Maloley | L. Klassen | S. Wees | H. Klein | G. Moore | J. O’dell | William Palmer | Nils Erikson | P. Maloley | Harry Klein | Vernon Garwood | William E. Palmer | Pierre Maloley
[1] O. Steinbrocker,et al. Therapeutic criteria in rheumatoid arthritis. , 1949, Journal of the American Medical Association.
[2] W. R. Mccrum,et al. Gold salts in the treatment of rheumatoid arthritis. A double-blind study. , 2020, Annals of internal medicine.
[3] R. M. Mason,et al. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. , 1975, Annals of the rheumatic diseases.
[4] M. Hochberg,et al. Adult and juvenile rheumatoid arthritis: current epidemiologic concepts. , 1981, Epidemiologic reviews.
[5] D. Mitchell,et al. Preliminary criteria for clinical remission in rheumatoid arthritis. , 1981, Arthritis and rheumatism.
[6] M. Guttadauria,et al. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. , 1983, Arthritis and rheumatism.
[7] M. Guttadauria,et al. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. , 1985, Arthritis and rheumatism.
[8] M. Weinblatt,et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. , 1985, The New England journal of medicine.
[9] J. Reading,et al. Reduced joint count indices in the evaluation of rheumatoid arthritis. , 1985, Arthritis and rheumatism.
[10] J. Lifson,et al. Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. , 1985, Annals of internal medicine.
[11] Robert S. Pinals,et al. A double‐blind, placebo‐controlled trial , 1986 .
[12] D. Symmons,et al. LONG-TERM OUTCOME OF TREATING RHEUMATOID ARTHRITIS: RESULTS AFTER 20 YEARS , 1987, The Lancet.
[13] P. Emery,et al. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study. , 1987, British journal of rheumatology.
[14] Evaluation of the American Rheumatism Association preliminary criteria for remission in rheumatoid arthritis: a prospective study. , 1987, The Journal of rheumatology.
[15] V. Wright,et al. Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis. , 1987, British journal of rheumatology.
[16] M. Weisman,et al. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[17] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[18] G. Alarcón,et al. Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. , 1989, Arthritis and rheumatism.
[19] F. Wolfe,et al. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. , 1990, The Journal of rheumatology.
[20] D. Felson,et al. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. , 1990, Arthritis and rheumatism.
[21] H. Paulus,et al. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group. , 1990, Arthritis and rheumatism.
[22] E. Morand,et al. Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice. , 1992, The Journal of rheumatology.
[23] D. Felson,et al. Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials. , 1992, Arthritis and rheumatism.
[24] M. Urowitz,et al. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis , 1992 .
[25] J. Kremer,et al. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. , 1992, Arthritis and rheumatism.
[26] M. Urowitz,et al. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. , 1992, Arthritis and rheumatism.
[27] P. Hannonen,et al. Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study. , 1993, Arthritis and rheumatism.
[28] M. Weinblatt,et al. The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin. , 1993, Arthritis and rheumatism.
[29] J J Anderson,et al. The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials , 1993 .
[30] T. Pincus,et al. Prediction of Long-Term Mortality in Patients with Rheumatoid Arthritis according to Simple Questionnaire and Joint Count Measures , 1994, Annals of Internal Medicine.
[31] J. Klippel,et al. Second-line drug therapy for rheumatoid arthritis. , 1994, The New England journal of medicine.
[32] F. Wolfe,et al. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. , 1994, Arthritis and rheumatism.
[33] F. Wolfe,et al. The mortality of rheumatoid arthritis. , 1994, Arthritis and rheumatism.
[34] D. Felson,et al. The efficacy and toxicity of combination therapy in rheumatoid arthritis. A meta-analysis. , 1994, Arthritis and rheumatism.